Biocrates Life Sciences Ag

biocrates and metanomics health have recently merged to create a new global leader in metabolomics and early disease detection. as a total solution provider, biocrates and metanomics health provide the broadest technology and product portfolio in the industry. the company has extensive expertise in targeted and global metabolic profiling, customized assay development, targeted screening kits, and data interpretation. finally, capabilities in cdx / diagnostic kit development make biocrates and metanomics health the preferred partner for all your requirements in metabolite analysis. biocrates’ metabolomics kits allow for the analysis of up to 400 metabolites across multiple analyte classes in a single run. these kits have contributed to more than 800 scientific publications and are being used in more than 100 mass spectrometry laboratories throughout the world. the whole range of analytical and data interpretation services is available through the company’s service laboratories in berlin